Used ViaOpta Simulator for iOS?


ViaOpta Simulator Analysis

AI Assisted Content ·

Not written by CNET Staff.

ViaOpta Simulator is an educational application designed for iPhone users interested in health and fitness. This free app provides users with valuable insights into various health conditions, particularly focusing on visual impairments. It employs interactive simulations to help users understand the challenges faced by individuals with eye diseases, enhancing empathy and awareness. The app also includes informative content about different conditions, treatment options, and resources for further learning.

Top Recommended Alternative

The application features user-friendly navigation and engaging visual elements that aim to educate users about the impact of visual impairments on daily life. By utilizing realistic scenarios, it encourages users to experience firsthand the difficulties that can arise from these conditions. Overall, ViaOpta Simulator serves as a comprehensive tool for anyone looking to deepen their understanding of health issues related to vision.

Enlarged image for ViaOpta Simulator
ViaOpta Simulator 0/1

Used ViaOpta Simulator for iOS?


Explore More


Full Specifications

GENERAL
Release
Latest update
Version
2.2
OPERATING SYSTEMS
Platform
iOS
Operating System
iOS 12.1.2
Additional Requirements
Compatible with: iphone4, iphone4, ipad2wifi, ipad2wifi, ipad23g, ipad23g, iphone4s, iphone4s, ipadthirdgen, ipadthirdgen, ipadthirdgen4g, ipadthirdgen4g, iphone5, iphone5, ipodtouchfifthgen, ipodtouchfifthgen, ipadfourthgen, ipadfourthgen, ipadfourthgen4g, ipadfourthgen4g, ipadmini, ipadmini, ipadmini4g, ipadmini4g
POPULARITY
Total Downloads
19
Downloads Last Week
0

Report Software

Last Updated


Developer’s Description

For Health Care Professionals:ViaOpta Simulator is a vision simulator app for the iPad designed to help health care professionals educate patients...

Download.com
Your review for ViaOpta Simulator
Download.com

AI Assisted Content Disclosure

Content created and reviewed by Softonic with information obtained from Novartis, using AI.

CNET's editorial team was not involved in the creation of this content. Opinions, analysis and reviews were not provided by CNET.